Wednesday, August 23, 2017

US FDA News: Ninjacof and Ninjacof A: Recall - Potential Burkholderia Cepacia Contamination

Use of a product that may contain B. cepacia could result in infections in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Read more: Ninjacof and Ninjacof A: Recall - Potential Burkholderia Cepacia Contamination